top

  Info

  • Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.

  Info

  • Utilizzare questo link per rimuovere la selezione effettuata.
Advances in Diagnosis and Management of Cutaneous Adverse Drug Reactions [[electronic resource] ] : Current and Future Trends / / edited by Neil H. Shear, Roni P. Dodiuk-Gad
Advances in Diagnosis and Management of Cutaneous Adverse Drug Reactions [[electronic resource] ] : Current and Future Trends / / edited by Neil H. Shear, Roni P. Dodiuk-Gad
Edizione [1st ed. 2019.]
Pubbl/distr/stampa Singapore : , : Springer Singapore : , : Imprint : Adis, , 2019
Descrizione fisica 1 online resource (XII, 314 p. 95 illus., 91 illus. in color.)
Disciplina 353.998
Soggetto topico Pharmacy
Pharmacology
Drug Safety and Pharmacovigilance
Pharmacology/Toxicology
ISBN 981-13-1489-6
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto Section I. Introduction -- 1. Introduction: Classification, Terminology, Epidemiology and Etiology of Cutaneous Adverse Drug Reactions -- Section II. Pathomechanisms of Cutaneous Adverse Drug Reactions -- 2. Immunology of Cutaneous Adverse Drug Reactions -- 3. Pharmacogenomics and Cutaneous Adverse Drug Reactions -- 4 Viral Reactivation in Cutaneous Adverse Drug Reactions -- 5. Using Technology to Learn About Immunology of Cutaneous Adverse Drug Reactions -- Section III. Clinical Perspectives of Cutaneous Adverse Drug Reactions -- 6. Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis (Epithelial Necrolysis) -- 7. Drug Reaction with Eosinophilia and Systemic Symptoms -- 8. Acute Generalized Exanthematous Pustulosis -- 9. Urticarial Reactions to Drugs -- 10. Dermatological Adverse Events from Cancer Treatments -- 11. Cutaneous Adverse Drug Reactions in Pediatric Population -- 12. Cutaneous Drug Reactions in the Elderly -- 13. Cutaneous Adverse Drug Reactions in Human Immunodeficiency Virus Patients -- 14. Cutaneous Adverse Drug Reactions from Anti-Tuberculosis Treatment -- Section IV. Approach to the Patient with a Cutaneous Adverse Drug Reaction -- 15. Practical Approach to Diagnosis and Management of Cutaneous Adverse Drug Reactions -- 16. Histopathology of Severe Drug Eruptions -- 17. Evaluation of Drug Safety Literature: A Guide for the Practicing Dermatologist -- 18. In vitro and in vivo tests in Cutaneous Adverse Drug Reactions -- 19. Pharmacovigilance of Cutaneous Adverse Drug Reactions -- Section V. Epilogue -- 20. Future Directions and Unmet Research Needs in Cutaneous Adverse Drug Reactions -- 21. Atlas of Cutaneous Adverse Drug Reactions.
Record Nr. UNINA-9910350239403321
Singapore : , : Springer Singapore : , : Imprint : Adis, , 2019
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Cardiovascular Safety in Drug Development and Therapeutic Use [[electronic resource] ] : New Methodologies and Evolving Regulatory Landscapes / / by J. Rick Turner, Dilip R. Karnad, Snehal Kothari
Cardiovascular Safety in Drug Development and Therapeutic Use [[electronic resource] ] : New Methodologies and Evolving Regulatory Landscapes / / by J. Rick Turner, Dilip R. Karnad, Snehal Kothari
Autore Turner J. Rick
Edizione [1st ed. 2017.]
Pubbl/distr/stampa Cham : , : Springer International Publishing : , : Imprint : Adis, , 2017
Descrizione fisica 1 online resource (XXVI, 333 p. 2 illus. in color.)
Disciplina 353.998
Soggetto topico Pharmacy
Cardiology
Drug Safety and Pharmacovigilance
ISBN 3-319-40347-8
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto The Central Importance of Cardiovascular Safety in Contemporary New Drug Development -- The Biological Basis of Drug Responses -- Cardiovascular Structure, Function, Pathophysiology, & Disease -- The Current Regulatory Landscape -- The "Comprehensive In Vitro Proarrhythmia Assay" Initiative -- The "Early ECG Assessment" Initiative -- The "Submission of Extended Digital ECG Data" Initiative -- Meta-analysis and Meta-methodology -- Current Regulatory Landscapes and their Potential Evolution -- Off-target Blood Pressure Responses to Non-cardiovascular Drugs -- Oncology Drug Development and Therapeutics: Cardiotoxicity Considerations -- Postmarketing Surveillance -- Regulatory Perspectives on General Drug Safety -- Future Directions in Cardiovascular Safety -- References.
Record Nr. UNINA-9910254496803321
Turner J. Rick  
Cham : , : Springer International Publishing : , : Imprint : Adis, , 2017
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Drug safety
Drug safety
Pubbl/distr/stampa [Mairangi Bay, Auckland, N.Z.], : Adis International
Disciplina 353.998
610
Soggetto topico Drugs - Side effects
Drugs - Toxicology
Toxicology
Pharmacoepidemiology
Drug-Related Side Effects and Adverse Reactions
Pharmacoépidémiologie
Médicaments - Effets secondaires
Médicaments - Toxicologie
Toxicologie
toxicology
Soggetto genere / forma Periodical
Fulltext
Internet Resources.
Periodicals.
periodicals.
Périodiques.
ISSN 1179-1942
Formato Materiale a stampa
Livello bibliografico Periodico
Lingua di pubblicazione eng
Record Nr. UNISA-996202316703316
[Mairangi Bay, Auckland, N.Z.], : Adis International
Materiale a stampa
Lo trovi qui: Univ. di Salerno
Opac: Controlla la disponibilità qui
Drug safety
Drug safety
Pubbl/distr/stampa [Mairangi Bay, Auckland, N.Z.], : Adis International
Disciplina 353.998
610
Soggetto topico Drugs - Side effects
Drugs - Toxicology
Toxicology
Pharmacoepidemiology
Drug-Related Side Effects and Adverse Reactions
Pharmacoépidémiologie
Médicaments - Effets secondaires
Médicaments - Toxicologie
Toxicologie
toxicology
Soggetto genere / forma Periodical
Fulltext
Internet Resources.
Periodicals.
periodicals.
Périodiques.
ISSN 1179-1942
Formato Materiale a stampa
Livello bibliografico Periodico
Lingua di pubblicazione eng
Record Nr. UNINA-9910481986503321
[Mairangi Bay, Auckland, N.Z.], : Adis International
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Pharmacovigilance [[electronic resource] ] : Critique and Ways Forward / / edited by I. Ralph Edwards, Marie Lindquist
Pharmacovigilance [[electronic resource] ] : Critique and Ways Forward / / edited by I. Ralph Edwards, Marie Lindquist
Edizione [1st ed. 2017.]
Pubbl/distr/stampa Cham : , : Springer International Publishing : , : Imprint : Adis, , 2017
Descrizione fisica 1 online resource (XXXI, 205 p. 16 illus., 3 illus. in color.)
Disciplina 353.998
Soggetto topico Pharmacy
Drug Safety and Pharmacovigilance
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto 1. How to learn Pharmacovigilance, now and in the Future -- 2. Lost in Regulation -- 3. What is the Future of Pharmacovigilance and how can we Make it as Good as Possible? -- 4. Some Other Ideas About the Future of Pharmacovigilance -- 5. Best Safety Practices now and in the Future -- 6. Is There a Benefit from the Medical Literature Monitoring Service of the EMA? -- 7. The Unified Drug Safety-Clinical Database -- 8. Behind the Scenes – ‘Silent Factors’ Influencing Pharmacovigilance Practice and Decisions -- 9. Shaking up Culture and Communication in PV [V6] -- 10. Broadening the Scope of Pharmacovigilance -- 11. Effective Treatment Matters: Revitalizing Pharmacoviglance -- 12. There are More Weber-Effects -- 13. Herbal and Traditional Medicines, Now and Future -- 14. The Concept of ‘Health’ -- 15. Impact of Referral Procedures on the Interaction of RMP and PSUR -- 16. Other Sources of Information for Monitoring Drug Safety: Now and in the Future -- 17. Ecopharmacovigilance.
Record Nr. UNINA-9910148857703321
Cham : , : Springer International Publishing : , : Imprint : Adis, , 2017
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Quick Guide to Good Clinical Practice [[electronic resource] ] : How to Meet International Quality Standard in Clinical Research / / by Cemal Cingi, Nuray Bayar Muluk
Quick Guide to Good Clinical Practice [[electronic resource] ] : How to Meet International Quality Standard in Clinical Research / / by Cemal Cingi, Nuray Bayar Muluk
Autore Cingi Cemal
Edizione [1st ed. 2017.]
Pubbl/distr/stampa Cham : , : Springer International Publishing : , : Imprint : Springer, , 2017
Descrizione fisica 1 online resource (XVIII, 237 p.)
Disciplina 353.998
Soggetto topico Pharmacy
Statistics 
Surgery
Medical education
Drug Safety and Pharmacovigilance
Statistics for Life Sciences, Medicine, Health Sciences
General Surgery
Medical Education
ISBN 3-319-44344-5
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto 1 Clinical Trials: Historical Aspects and Importance and New Drug Developments -- 2 The Definition of GCP -- 3 The Principles of GCP -- 4 The Drug Development Process and Evolution of Regulations -- 5 Planning Clinical Research -- 6 Preparation of Ethics Committee (IRB) Proposal -- 7 Preparation of Informed Consent -- 8 Preparation of Findings Tables -- 9 Setting the Ideal Statistical Methods -- 10 The Duties of a Clinical Research Coordinator -- 11 The Duties of Clinical Researchers -- 12 The Phases of Clinical Studies -- 13 Safety in Clinical Trials -- 14 Setting the Size -- 15 Setting the Ideal Method -- 16 Ethics of Clinical Research -- 17 Recruitment and Enrolment -- 18 Why we need Clinical Consent and Other Documentation -- 19 Monitoring the Trial -- 20 Inspection -- 21 Ethics - Institutional Review Board/Independent Ethics Committee(IRB/IEC) -- 22 Responsibilities of the Investigator -- 23 Responsibilities of the Sponsor -- 24.Clinical Trial Protocols.
Record Nr. UNINA-9910151663203321
Cingi Cemal  
Cham : , : Springer International Publishing : , : Imprint : Springer, , 2017
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui